Stryker Partners with CMR Surgical, Becoming Exclusive U.S. Sales Agent for Versius Robotics
CMR Surgical has secured a significant investment from Stryker, with the medical device giant committing $400 million to act as the exclusive U.S. sales agent for the Versius robotics system. The Versius platform is a modular, minimally‑invasive surgical robot designed for a range of specialties, including colorectal, gynecologic, and general surgery. By leveraging Stryker’s established sales network and clinical support infrastructure, the partnership aims to broaden surgeon access to the Versius system and accelerate its adoption across American hospitals and ambulatory surgical centers. The investment reflects the growing trend of large medtech companies integrating advanced robotics into their portfolios to meet rising demand for precision‑driven, minimally invasive procedures.